We are proud to share that MSInsight has been awarded 2nd place and 50K € at Hack4Hope 2025, with our CEO Arnaud Cutivet pitching on behalf of the team.
This recognition is a strong encouragement for our work to bring precision oncology and microsatellite instability (MSI) innovation to pediatric cancer care.
🙏 Thank you to:
- The Hack4Hope jury and organizers for their trust
- The PSCC for their continued support
- Future4care for hosting this year’s edition
- All the experts, partners and speakers who made the event so impactful
👏 Congratulations as well to our fellow finalist teams — Sawera Health Foundation, Hippoxis, Innov’nCare, Lucid Genomics, TK-002 (Takis), ORINOVA, Kindling Bio, Little Journey — for their dedication to advancing pediatric cancer innovation.
We’re excited to put this award to work and continue building solutions that can make a real difference for children with cancer and their families.
